FIGURE 3
Presence of mSEPT9 was significantly associated with EOCRC survival status. Comparison of presence of mSEPT9, normalized by batch and ACTB, by stage (A; P = 0.06, Ptrend = 0.13), tumor grade (B; P = 0.98, Ptrend = 0.88), tumor site (C; P = 0.65), and survival status (D; P = 0.02).

Presence of mSEPT9 was significantly associated with EOCRC survival status. Comparison of presence of mSEPT9, normalized by batch and ACTB, by stage (A; P = 0.06, Ptrend = 0.13), tumor grade (B; P = 0.98, Ptrend = 0.88), tumor site (C; P = 0.65), and survival status (D; P = 0.02).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept